Research Opportunities

Should you be interested in the study participation, please contact us at: rberkovich.research@gmail.com

Currently Enrolling Studies

REMASTER:

Phase 3 Study of Remibrutinib in Secondary Progressive Multiple Sclerosis

Protocol # CLOU064P12301

Site: 5014

Sponsor: Novartis

ClinicalTrials.gov Identifier: NCT07225504

Link

MONARCH:

Phase 3 Study of Orelabrutinib in Secondary Progressive Multiple Sclerosis

Protocol # ZB020-03-002

Site: 0125

Sponsor: Zenas BioPharma

ClinicalTrials.gov Identifier: NCT07299019

Link

PriMroSe:

Phase 3 Study of Orelabrutinib in Primary Progressive Multiple Sclerosis

Protocol # ZB020-03-001

Site: 0125

Sponsor: Zenas BioPharma

ClinicalTrials.gov Identifier: NCT07067463

Link

FREXCITE:

Phase 3 Study of Frexalimab in Relapsing and Secondary Progressive Multiple Sclerosis

Protocol # EFC18098

Site: 8400005

Sponsor: Sanofi

ClinicalTrials.gov Identifier: NCT07325292

Link

ENABLE:

Phase 4 Study of Ublituximab in Relapsing Multiple Sclerosis

Protocol # TG1101-RMS406

Site: WDA

Sponsor: TG Therapeutics

ClinicalTrials.gov Identifier: NCT06433752

Link

COAST:

Phase 4 Study of Ozanimod in Relapsing Multiple Sclerosis

Protocol # 23-1686

Site: RGB

Sponsor: University of Colorado, Denver

ClinicalTrials.gov Identifier: NCT06529406

Link

Ongoing Studies (enrollment closed)

FREXALT:

Phase 3 Study of Frexalimab in Relapsing Multiple Sclerosis

Protocol # EFC 17919

Site: 8400005

Sponsor: Sanofi

ClinicalTrials.gov Identifier: NCT06141473

Link

FREVIVA:

Phase 3 Study of Frexalimab in Progressive Multiple Sclerosis

Protocol # EFC 17504

Site: 8400005

Sponsor: Sanofi

ClinicalTrials.gov Identifier: NCT06141486

Link

REMODEL:

Phase 3 Study of Remibrutinib in Relapsing Multiple Sclerosis

Protocol # CLOU064C12302

Site: 5064

Sponsor: Novartis

ClinicalTrials.gov Identifier: NCT05156281

Link

FILIOS:

Phase 3 Study of Ofatumumab in Relapsing and Progressive Multiple Sclerosis

Protocol # COMB157Q12301

Site: 5060

Sponsor: Novartis

ClinicalTrials.gov Identifier: NCT06869785

Link

LTS17043

Phase 3 Study of Tolebrutinib in Relapsing Multiple Sclerosis

 Protocol # NCT06372145

 Site: 8400059

Sponsor: Sanofi

ClinicalTrials.gov Identifier: NCT06372145

Link

ZENAS

Phase 2 Study of Obexelimab in Relapsing Multiple Sclerosis

Protocol # ZB012-02-002

Site: 1003

Sponsor: BioPharma

ClinicalTrials.gov Identifier: NCT06564311

Link

ENSURE-1

Phase 3 Study of Vidofludimus Calcium in Relapsing Multiple Sclerosis

Protocol # P3-IMU-838-RMS-01

Site: 100112

Sponsor: Immunic AG

ClinicalTrials.gov Identifier: NCT05134441

Link